- Home
- CLVT vs WGS Comparison
CLVT vs WGS Comparison
Compare CLVT & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLVT
- WGS
- Stock Information
- Founded
- CLVT 2016
- WGS 2017
- Country
- CLVT United Kingdom
- WGS United States
- Employees
- CLVT N/A
- WGS N/A
- Industry
- CLVT EDP Services
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- CLVT Technology
- WGS Technology
- Exchange
- CLVT Nasdaq
- WGS Nasdaq
- Market Cap
- CLVT 2.5B
- WGS 2.4B
- IPO Year
- CLVT N/A
- WGS N/A
- Fundamental
- Price
- CLVT $3.24
- WGS $131.50
- Analyst Decision
- CLVT Hold
- WGS Strong Buy
- Analyst Count
- CLVT 5
- WGS 9
- Target Price
- CLVT $4.83
- WGS $121.67
- AVG Volume (30 Days)
- CLVT 3.7M
- WGS 597.9K
- Earning Date
- CLVT 10-29-2025
- WGS 10-28-2025
- Dividend Yield
- CLVT N/A
- WGS N/A
- EPS Growth
- CLVT N/A
- WGS N/A
- EPS
- CLVT N/A
- WGS 0.07
- Revenue
- CLVT $2,501,200,000.00
- WGS $402,190,000.00
- Revenue This Year
- CLVT N/A
- WGS $36.01
- Revenue Next Year
- CLVT N/A
- WGS $19.01
- P/E Ratio
- CLVT N/A
- WGS $1,788.17
- Revenue Growth
- CLVT N/A
- WGS 50.50
- 52 Week Low
- CLVT $3.04
- WGS $55.17
- 52 Week High
- CLVT $6.72
- WGS $146.00
- Technical
- Relative Strength Index (RSI)
- CLVT 27.73
- WGS 58.30
- Support Level
- CLVT $3.55
- WGS $121.00
- Resistance Level
- CLVT $3.82
- WGS $146.00
- Average True Range (ATR)
- CLVT 0.15
- WGS 9.42
- MACD
- CLVT -0.01
- WGS 1.19
- Stochastic Oscillator
- CLVT 6.45
- WGS 53.93
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.